Clearside Biomedical Inc. (CLSD)
NASDAQ: CLSD
· Real-Time Price · USD
0.79
-0.02 (-2.59%)
At close: Jun 27, 2025, 3:59 PM
0.81
2.33%
After-hours: Jun 27, 2025, 04:31 PM EDT
-2.59% (1D)
| Bid | 0.76 |
| Market Cap | 61.4M |
| Revenue (ttm) | 1.43M |
| Net Income (ttm) | -30.81M |
| EPS (ttm) | -0.41 |
| PE Ratio (ttm) | -1.93 |
| Forward PE | -1.37 |
| Analyst | Buy |
| Ask | 0.81 |
| Volume | 130,313 |
| Avg. Volume (20D) | 241,362 |
| Open | 0.81 |
| Previous Close | 0.81 |
| Day's Range | 0.78 - 0.82 |
| 52-Week Range | 0.70 - 1.65 |
| Beta | 2.06 |
About CLSD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLSD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLSD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Clearside Biomedical Inc. is scheduled to release its earnings on Aug 11, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+14.82%
Clearside Biomedical shares are trading higher aft...
Unlock content with
Pro Subscription
3 months ago · seekingalpha.com
Clearside Biomedical, Inc. (CLSD) Q4 2024 Earnings Conference Call TranscriptClearside Biomedical, Inc. (NASDAQ:CLSD ) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Company Participants Jenny Kobin - IR George Lasezkay - CEO Victor Chong - Chief Medical Officer Ch...
